Fig. 8

First derivative synchronous fluorescence spectra at 409 nm (A) different concentrations of lacidipine (50–300 ng/mL). (B) Determination of five component mixtures of lacidipine and degradation product in spiked human plasma.
First derivative synchronous fluorescence spectra at 409 nm (A) different concentrations of lacidipine (50–300 ng/mL). (B) Determination of five component mixtures of lacidipine and degradation product in spiked human plasma.